Effect of multidisciplinary disease management for hospitalized heart failure under a national health insurance programme

Journal of Cardiovascular Medicine

Volumn 16, Issue 9, 2015, Pages 616-624

  Mao, Chun Tai ^a,b   Liu, Min Hui ^a,b,c   Hsu, Kuang Hung ^d   Fu, Tieh Cheng ^a,b   Wang, Jong Shyan ^d   Huang, Yu Yen ^a,b   Yang, Ning I ^a,b   Wang, Chao Hung ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Heart failure; High population density; Multidisciplinary disease management programme; National health insurance system

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SODIUM;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEART FAILURE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDISCIPLINARY DISEASE MANAGEMENT PROGRAM; NATIONAL HEALTH INSURANCE; PATIENT CARE; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; AGED; DISEASE MANAGEMENT; EPIDEMIOLOGY; HOSPITALIZATION; KAPLAN MEIER METHOD; MORTALITY; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA; TAIWAN;

AGED; DISEASE MANAGEMENT; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT CARE TEAM; PATIENT READMISSION; TAIWAN;

EID: 84942816140     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000089     Document Type: Article

References (27)

1. Riegel B, Moser DK, Anker SD, et al. State of the science: promoting selfcare in persons with heart failure: a scientific statement from the American Heart Association. Circulation 2009; 120: 1141-1163.
2. Del Sindaco D, Pulignano G, Minardi G, et al. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. J Cardiovasc Med (Hagerstown) 2007; 8: 324-329.
3. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-1195.
4. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002; 39: 83-89.
5. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J 2004; 25: 1570-1595.
6. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819.
7. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients: a meta-analysis. Eur J Heart Fail 2005; 7: 1133-1144.
8. Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007; 33: 942-950.
9. Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M. Clinical service organisation for heart failure. Cochrane Database Syst Rev 2012; 9: CD002752.
10. Liu MH, Wang CH, Huang YY, et al. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure. J Cardiovasc Med (Hagerstown) 2012; 13: 299-306.
11. Liu MH, Wang CH, Huang YY, et al. Edema index-guided disease management improves 6-month outcomes of patients with acute heart failure. Int Heart J 2012; 53: 11-17.
12. Battler A, Karliner JS, Higgins CB, et al. The initial chest x-ray in acute myocardial infarction: prediction of early and late mortality and survival. Circulation 1980; 61: 1004-1009.
13. Stromberg A, Martensson J, Fridlund B, Levin LA, Karlsson JE, Dahlstrom U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. Eur Heart J 2003; 24: 1014-1023.
14. Atienza F, Anguita M, Martinez-Alzamora N, et al. Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail 2004; 6: 643-652.
15. Jaarsma T, van der Wal MH, Lesman-Leegte I, et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 2008; 168: 316-324.
16. Gamble JM, Eurich DT, Ezekowitz JA, Kaul P, Quan H, McAlister FA. Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system. Circ Heart Fail 2011; 4: 317-323.
17. O'Connor CM, Miller AB, Blair JE, et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J 2010; 159: 841-849; e1.
18. Bonow RO, Ganiats TG, Beam CT, et al. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association- Physician Consortium for Performance Improvement. J Am Coll Cardiol 2012; 59: 1812-1832.
19. Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 2006; 27: 3011-3017.
20. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118 465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007; 13: 422-430.
21. Wang NC, Maggioni AP, Konstam MA, et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 2008; 299: 2656-2666.
22. Roccaforte R, Demers C, Baldassarre F, Kteo K, Yusuf S. Corrigendum to 'Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis' [Eur J Heart Fail 7 (2005) 1133-1144]. Eur J Heart Fail 2006; 8: 223-224.
23. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000; 283: 1295-1302.
24. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-1675.
25. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-2199.
26. Sleight P. Angiotensin II and trials of cardiovascular outcomes. Am J Cardiol 2002; 89 (Suppl): 11A-17A.
27. Carson P, Tognoni G, Cohn JN. Effect of Valsartan on hospitalization: results from Val-HeFT. J Card Fail 2003; 9: 164-171.